TNFSF11 and osteoporosis: Collectively, these findings suggest that natural products can suppress osteoclastogenesis by targeting the RANKL–RANK–MAPK–NFATc1 axis, providing mechanistic insight and pharmacological rationale for their application in the prevention and treatment of bone-resorptive diseases such as osteoporosis.